Fengcai Zhu to Public Health Surveillance
This is a "connection" page, showing publications Fengcai Zhu has written about Public Health Surveillance.
Connection Strength
0.074
-
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial. Cancer Med. 2019 10; 8(14):6195-6211.
Score: 0.074